Cell-type-specific expression analysis of liver transcriptomics with clinical parameters to decipher the cause of intrahepatic inflammation in chronic hepatitis B

Abstract

Functional cure for chronic hepatitis B (CHB) remains challenging due to the lack of direct intervention methods for hepatic inflammation. Multi-omics research offers a promising approach to understand hepatic inflammation mechanisms in CHB. A Bayesian linear model linked gene expression with clinical parameters, and population-specific expression analysis (PSEA) refined bulk gene expression into specific cell types across different clinical phases. These models were integrated into our analysis of key factors like inflammatory cells, immune activation, T cell exhaustion, chemokines, receptors, and interferon-stimulated genes (ISGs). Validation through multi-immune staining in liver specimens from CHB patients bolstered our findings. In CHB patients, increased gene expression related to immune cell activation and migration was noted. Marker genes of macrophages, T cells, immune-negative regulators, chemokines, and ISGs showed a positive correlation with serum alanine aminotransferase (ALT) levels but not hepatitis B virus DNA levels. The PSEA model confirmed T cells as the source of exhausted regulators, while macrophages primarily contributed to chemokine expression. Upregulated ISGs (ISG20, IFI16, TAP2, GBP1, PSMB9) in the hepatitis phase were associated with T cell and macrophage infiltration and positively correlated with ALT levels. Conversely, another set of ISGs (IFI44, ISG15, IFI44L, IFI6, MX1) mainly expressed by hepatocytes and B cells showed no correlation with ALT levels. Our study presents a multi-omics analysis integrating bulk transcriptomic, single-cell sequencing data, and clinical data from CHB patients to decipher the cause of intrahepatic inflammation in CHB. The findings confirm that macrophages secrete chemokines like CCL20, recruiting exhausted T cells into liver tissue; concurrently, hepatocyte innate immunity is suppressed, hindering the antiviral effects of ISGs.

Keywords

chronic hepatitis B / immune infiltration / innate immunity / population-specific expression analysis

References

[1] Hepatitis B - World Health Organization (WHO), https://www.who.int/news-room/fact-sheets/detail/hepatitis-b

[2] Tassopoulos, Nicolaos C., George J. Papaevangelou, Maria H. Sjogren, Anastasia Roumeliotou-Karayannis, John L. Gerin, and Robert H. Purcell. 1987. “Natural History of Acute Hepatitis B Surface Antigen-Positive Hepatitis in Greek Adults.” Gastroenterology 92: 1844-1850. https://doi.org/10.1016/0016-5085(87)90614-7

[3] Vanwolleghem, Thomas, Jun Hou, van Gertine Oord, Arno C. Andeweg, Albertus Dominicus Marcellinus Erasmus Osterhaus, Suzan D. Pas, Harry L. A. Janssen, and Andre Boonstra. 2015. “Re-Evaluation of Hepatitis B Virus Clinical Phases by Systems Biology Identifies Unappreciated Roles for the Innate Immune Response and B Cells.” Hepatology 62: 87-100. https://doi.org/10.1002/hep.27805

[4] Lebossé, Fanny, Barbara Testoni, Judith Fresquet, Floriana Facchetti, Enrico Galmozzi, Maëlenn Fournier, Valérie Hervieu, et al. 2017. “Intrahepatic Innate Immune Response Pathways Are Downregulated in Untreated Chronic Hepatitis B.” Journal of Hepatology 66: 897-909. https://doi.org/10.1016/j.jhep.2016.12.024

[5] van Buuren, Nicholas, Ricardo Ramirez, Scott Turner, Diana Chen, Vithika Suri, Abhishek Aggarwal, and Christina Moon, et al. 2022. “Characterization of the Liver Immune Microenvironment in Liver Biopsies From Patients With Chronic HBV Infection.” JHEP Reports 4: 100388. https://doi.org/10.1016/j.jhepr.2021.100388

[6] Montanari, Noe Rico, Ricardo Ramírez, Abhishek Aggarwal, Nick van Buuren, Michael Doukas, Christina Moon, Scott Turner, et al. 2022. “Multi-Parametric Analysis of Human Livers Reveals Variation in Intrahepatic Inflammation Across Phases of Chronic Hepatitis B Infection.” Journal of Hepatology 77: 332-343. https://doi.org/10.1016/j.jhep.2022.02.016

[7] Zhang, Chao, Jiesheng Li, Yongqian Cheng, Fanping Meng, Jin-Wen Song, Xing Fan, Hongtao Fan, et al. 2023. “Single-Cell RNA Sequencing Reveals Intrahepatic and Peripheral Immune Characteristics Related to Disease Phases in HBV-Infected Patients.” Gut 72: 153-167. https://doi.org/10.1136/gutjnl-2021-325915

[8] Kuhn, Alexandre, Doris Thu, Henry J. Waldvogel, Richard L. M. Faull, and Ruth Luthi-Carter. 2011. “Population-Specific Expression Analysis (PSEA) Reveals Molecular Changes in Diseased Brain.” Nature Methods 8: 945-947. https://doi.org/10.1038/nmeth.1710

[9] Maini, Mala K., and Adam J. Gehring. 2016. “The Role of Innate Immunity in the Immunopathology and Treatment of HBV Infection.” Journal of Hepatology 64: S60-S70. https://doi.org/10.1016/j.jhep.2016.01.028

[10] Sitia, Giovanni, Masanori Isogawa, Matteo Iannacone, Iain L. Campbell, Francis V. Chisari, and Luca G. Guidotti. 2004. “MMPs are Required for Recruitment of Antigen-Nonspecific Mononuclear Cells into the Liver by CTLs.” Journal of Clinical Investigation 113: 1158-1167. https://doi.org/10.1172/JCI200421087

[11] Rehermann, Barbara, Patricia Fowler, John Sidney, John Person, Allan Redeker, Michael Brown, Bernard Moss, Alessandro Sette, and Francis V. Chisari. 1995. “The Cytotoxic T Lymphocyte Response to Multiple Hepatitis B Virus Polymerase Epitopes During and After Acute Viral Hepatitis.” Journal of Experimental Medicine 181: 1047-1058. https://doi.org/10.1084/jem.181.3.1047

[12] Boni, Carolina, Paola Fisicaro, Caterina Valdatta, Barbara Amadei, Paola Di Vincenzo, Tiziana Giuberti, Diletta Laccabue, et al. 2007. “Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection.” Journal of Virology 81: 4215-4225. https://doi.org/10.1128/JVI.02844-06

[13] Park, Jang-June, David K. Wong, Abdus S. Wahed, William M. Lee, Jordan J. Feld, Norah Terrault, Mandana Khalili, et al. 2016. “Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.” Gastroenterology 150: 684-695.e5. https://doi.org/10.1053/j.gastro.2015.11.050

[14] Rossi, Marzia, Andrea Vecchi, Camilla Tiezzi, Valeria Barili, Paola Fisicaro, Amalia Penna, Ilaria Montali, et al. 2023. “Phenotypic CD8 T Cell Profiling in Chronic Hepatitis B to Predict HBV-Specific CD8 T Cell Susceptibility to Functional Restoration in Vitro.” Gut 72: 2123-2137. https://doi.org/10.1136/gutjnl-2022-327202

[15] Wang, Xiaowen, Qingyang Dong, Qian Li, Yuanyuan Li, Dianyuan Zhao, Jinjie Sun, Junliang Fu, et al. 2018. “Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients.” Gastroenterology 154: 2222-2236. https://doi.org/10.1053/j.gastro.2018.03.021

[16] Sachiyo, Yoshio, Yohei Mano, Hiroyoshi Doi, Hirotaka Shoji, Tomonari Shimagaki, Yuzuru Sakamoto, Hironari Kawai, et al 2018. “Cytokine and Chemokine Signatures Associated With Hepatitis B Surface Antigen Loss in Hepatitis B Patients.” JCI Insight 3: e122268. https://doi.org/10.1172/jci.insight.122268

[17] Maini, Mala K., Carolina Boni, Graham S. Ogg, Abigail S. King, Stephanie Reignat, Chun Kyon Lee, Juan R. Larrubia, et al. 1999. “Direct Ex Vivo Analysis of Hepatitis B Virus-Specific CD8(+) T Cells Associated With the Control of Infection.” Gastroenterology 117: 1386-1396. https://doi.org/10.1016/s0016-5085(99)70289-1

[18] Tan, Anthony T., Sarene Koh, Winnie Goh, Heng Yee Zhe, Adam J. Gehring, Seng Gee Lim, and Antonio Bertoletti. 2010. “A Longitudinal Analysis of Innate and Adaptive Immune Profile During Hepatic Flares in Chronic Hepatitis B.” Journal of Hepatology 52: 330-339. https://doi.org/10.1016/j.jhep.2009.12.015

[19] Isogawa, Masanori, Michael D. Robek, Yoshihiro Furuichi, and Francis V. Chisari. 2005. “Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication in Vivo.” Journal of Virology 79: 7269-7272. https://doi.org/10.1128/JVI.79.11.7269-7272.2005

[20] Wu, Jun, Mengji Lu, Zhongji Meng, Martin Trippler, Ruth Broering, Agnes Szczeponek, Frank Krux, et al. 2007. “Toll-Like Receptor-Mediated Control of HBV Replication By Nonparenchymal Liver Cells in Mice.” Hepatology 46: 1769-1778. https://doi.org/10.1002/hep.21897

[21] Zhang, Xiaoyong, Zhiyong Ma, Hongyan Liu, Jia Liu, Zhongji Meng, Ruth Broering, Dongliang Yang, et al. 2012. “Role of Toll-Like Receptor 2 in the Immune Response Against Hepadnaviral Infection.” Journal of Hepatology 57: 522-528. https://doi.org/10.1016/j.jhep.2012.05.004

[22] Li, Jianhua, Kuancheng Liu, Yang Liu, Yan Xu, Fei Zhang, Huijuan Yang, Jiangxia Liu, et al. 2013. “Exosomes Mediate the Cell-To-Cell Transmission of IFN-α-Induced Antiviral Activity.” Nature Immunology 14: 793-803. https://doi.org/10.1038/ni.2647

[23] Li, Kui, and Stanley M. Lemon. 2013. “Innate Immune Responses in Hepatitis C Virus Infection.” Seminars in Immunopathology 35: 53-72. https://doi.org/10.1007/s00281-012-0332-x

[24] Tan, Guangyun, Zhaohong Yi, Hongxiao Song, Fengchao Xu, Feng Li, Roghiyh Aliyari, Hong Zhang, et al. 2019. “Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation.” Cell Reports 29: 3551-3563.e3. https://doi.org/10.1016/j.celrep.2019.11.041

[25] Metz, Philippe, Eva Dazert, Alessia Ruggieri, Johanna Mazur, Lars Kaderali, Artur Kaul, Ulf Zeuge, et al. 2012. “Identification of Type I and Type II Interferon-Induced Effectors Controlling Hepatitis C Virus Replication.” Hepatology 56: 2082-2093. https://doi.org/10.1002/hep.25908

[26] Liu, Hongyan, Fahong Li, Xiaoyong Zhang, Jie Yu, Jinyu Wang, Jia Jia, Xueping Yu, et al. 2018. “Differentially Expressed Intrahepatic Genes Contribute to Control of Hepatitis B Virus Replication in the Inactive Carrier Phase.” Journal of the Infectious Diseases 217: 1044-1054. https://doi.org/10.1093/infdis/jix683

[27] Goodman, Zachary D. 2007. “Grading and Staging Systems for Inflammation and Fibrosis in Chronic Liver Diseases.” Journal of Hepatology 47: 598-607. https://doi.org/10.1016/j.jhep.2007.07.006

[28] Damien, Bertheloot, Eicke Latz, and Bernardo S. Franklin. 2021. “Necroptosis, Pyroptosis and Apoptosis: An Intricate Game of Cell Death.” Cellular & Molecular Immunology 18: 1106-1121. https://doi.org/10.1038/s41423-020-00630-3

[29] MacParland, Sonya A., Jeff C. Liu, Xue-Zhong Ma, Brendan T. Innes, Agata M. Bartczak, Blair K. Gage, Justin Manuel, et al. 2018. “Single Cell RNA Sequencing of Human Liver Reveals Distinct Intrahepatic Macrophage Populations.” Nature Communications 9: 4383. https://doi.org/10.1038/s41467-018-06318-7

[30] Aizarani, Nadim, Antonio Saviano, Sagar, Laurent Mailly, Sarah Durand, Josip S. Herman, Patrick Pessaux, Thomas F. Baumert, and Dominic Grün. 2019. “A Human Liver Cell Atlas Reveals Heterogeneity and Epithelial Progenitors.” Nature 572: 199-204. https://doi.org/10.1038/s41586-019-1373-2

[31] Philippe, Clauss, Bénédicte Kenmei, and Jean Christophe Beyler. 2005. “The Periodic-Linear Model of Program Behavior Capture.” In Lecture Notes in Computer Science, edited by José C. Cunha and Pedro D. Medeiros, Berlin, Heidelberg: Springer.

[32] Mala, K Maini, and Laura J. Pallett. 2018. “Defective T-Cell Immunity in Hepatitis B Virus Infection: Why Therapeutic Vaccination Needs a Helping Hand.” Lancet Gastroenterology & Hepatology 3: 192-202. https://doi.org/10.1016/S2468-1253(18)30007-4

[33] Zhang, Xiaonan, Wei Lu, Ye Zheng, Weixia Wang, Lu Bai, Liang Chen, Yanling Feng, Zhanqing Zhang, and Zhenghong Yuan. 2016. “In Situ Analysis of Intrahepatic Virological Events in Chronic Hepatitis B Virus Infection.” Journal of Clinical Investigation 126: 1079-1092. https://doi.org/10.1172/JCI83339

[34] Hui-Lin, Wu, Tzu-Hung Hsiao, Pei-Jer Chen, Siao-Han Wong, Jia-Horng Kao, Ding-Shinn Chen, Jo-Yang Lu, et al. 2016. “Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients.” Scientific Reports 6: 31349. https://doi.org/10.1038/srep31349

[35] Raivo, Kolde. 2019. “Pheatmap: Pretty Heatmaps.”

[36] Ritchie, Matthew E., Belinda Phipson, Di Wu, Yifang Hu, Charity W. Law, Wei Shi, and Gordon K. Smyth. 2015. “Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies.” Nucleic Acids Research 43: e47. https://doi.org/10.1093/nar/gkv007

[37] Shi, Leming, Leming Shi, Laura H. Reid, Wendell D. Jones, Richard Shippy, Janet A. Warrington, Shawn C. Baker, et al., MAQC Consortium. 2006. “The MicroArray Quality Control (MAQC) Project Shows Inter- and Intraplatform Reproducibility of Gene Expression Measurements.” Nature Biotechnology 24: 1151-1161. https://doi.org/10.1038/nbt1239

[38] Alboukadel, Kassambara, and Fabian Mundt. 2020. “Factoextra Extract and Visualize the Results of Multivariate Data Analyses.”

[39] Li, Shuzhao, Nadine Rouphael, Sai Duraisingham, Sandra Romero-Steiner, Scott Presnell, Carl Davis, Daniel S. Schmidt, et al. 2014. “Molecular Signatures of Antibody Responses Derived From a Systems Biology Study of Five Human Vaccines.” Nature Immunology 15: 195-204. https://doi.org/10.1038/ni.2789

[40] Ruben, Dries, Zhu Qian, Li Huipeng, Dong Rui, and Yuan Guo-Cheng. 2022. “Plot UMAP Results Either on Already Run Results or Run First and Then Plot.”

[41] Jonah, Gabry, and Ben Goodrich. 2020. “rstanarm: Bayesian applied regression modeling via Stan.”

RIGHTS & PERMISSIONS

2024 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.